Propionyl-Carnitine

Propionyl-Carnitine

SCHEMBL527837

CC(=O)C(=O)O.CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.85
KMT2A Q03164 5/20 0.85
CYP2C19 P33261 2/20 0.85
RECQL P46063 1/20 0.85
CYP1A2 P05177 4/20 0.64
HRH1 P35367 1/20 0.64
MAPT P10636 4/20 0.59
SLC25A20 O43772 3/20 0.59
TP53 P04637 3/20 0.59
TSHR P16473 3/20 0.59
CYP2D6 P10635 2/20 0.59
SLC6A5 Q9Y345 2/20 0.59
CYP2C9 P11712 2/20 0.59
HIF1A Q16665 2/20 0.59
KDM4E B2RXH2 1/20 0.59
CYP3A4 P08684 1/20 0.59
NFKB1 P19838 1/20 0.59
THPO P40225 1/20 0.59
HSD17B10 Q99714 1/20 0.59
LMNA P02545 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionyl-Carnitine SCHEMBL156850 0.92 MEN1 (1.00) MEN1KMT2ACYP2C19RECQLCYP1A2
Levocarnitine Propionate SCHEMBL464940 0.92 MEN1 (1.00) MEN1KMT2ACYP2C19RECQLCYP1A2
Propionyl-Carnitine SCHEMBL994714 0.92 MEN1 (1.00) MEN1KMT2ACYP2C19RECQLCYP1A2
Propionyl-Carnitine SCHEMBL19617435 0.91 MEN1 (0.90) MEN1KMT2ACYP2C19RECQLCYP1A2
Levocarnitine Propionate SCHEMBL3005249 0.91 MEN1 (0.97) MEN1KMT2ACYP2C19RECQLCYP1A2
Levocarnitine Propionate SCHEMBL1358528 0.91 MEN1 (0.97) MEN1KMT2ACYP2C19RECQLCYP1A2
Propionyl-Carnitine SCHEMBL1358526 0.91 MEN1 (0.97) MEN1KMT2ACYP2C19RECQLCYP1A2
Levocarnitine Propionate SCHEMBL3039334 0.87 MEN1 (0.82) MEN1KMT2ACYP2C19RECQLCYP1A2
Levocarnitine Propionate SCHEMBL7941524 0.87 MEN1 (0.82) MEN1KMT2ACYP2C19RECQLCYP1A2
Levocarnitine Propionate SCHEMBL2232689 0.87 MEN1 (0.82) MEN1KMT2ACYP2C19RECQLCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598873-A2 BIOMARKERS FOR PROSTATE CANCER AND METHODS USING THE SAME Metabolon, Inc. (US) 2013-06-05 EP disclosed
WO-2012015904-A2 BIOMARKERS FOR PROSTATE CANCER AND METHODS USING THE SAME METABOLON, INC. (US) 2012-02-02 WO disclosed